However, we reported that PD-L1 positivity in NSCLC samples is around 20% by immunohistochemistry and in a larger cohort, including 982 patients, 314 (32.0%) specimens were positive for PD-L1 expression [38]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.